Lokman Hekim Istanbul Hospital
| Turkey | Thailand | South Korea | |
| Leiomyosarcoma Removal | ≈ AUD $10,800 | ≈ AUD $7,900 | ≈ AUD $20,100 |
Dr. Esra Ozbasli is a board-certified OB-GYN and Genital Cosmetic Surgeon in Istanbul. She specializes in robotic surgery and women's aesthetic procedures. Dr. Ozbasli practiced as an academician at Acıbadem University for 12 years. She is also ECFMG-accredited for medical practice in the United States.
Professor Mehmet Karaca is a senior specialist in gynecological oncology surgery at Medical Park Antalya Hospital Complex. He holds a specific subspecialty licence in surgical oncology from the Ministry of Health.
Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.
Dr Balcioglu is a general surgeon at Hisar Hospital Intercontinental who specialises in minimally invasive gastrointestinal surgery and soft tissue mass removal.
The primary treatment for leiomyosarcoma removal in Turkish hospitals is complete surgical resection, often combined with adjuvant chemotherapy. Surgery aims to remove the tumour entirely, with options including pelvic exenteration for extensive cases. Radiation therapy is used selectively for high-grade or abdominal tumours.
Bookimed Expert Insight: Turkish hospitals with Joint Commission International (JCI) and ISO certifications provide multidisciplinary sarcoma care. Istanbul clinics like Lokman Hekim and Acibadem ensure expert surgical teams and comprehensive chemotherapy regimens for leiomyosarcoma. Patients benefit from systems that combine surgery with tailored chemotherapy and limited use of radiation.
Patient Consensus: Surgery is essential and aimed at removing the whole tumour. Patients note that chemotherapy is routine after surgery, often following established international protocols. Radiation is less common but used when tumours are aggressive or located in the abdomen. Australian patients appreciate clear communication and coordination with oncologists before and after treatment in Turkey.
Leiomyosarcoma removal in Turkey has a strong success rate, supported by expert oncology teams and advanced treatments like adjuvant chemotherapy and radiation. Top hospitals with Joint Commission International (JCI) accreditation provide specialised care, managing complex cases and offering crucial follow-up for metastasis control.
Bookimed Expert Insight: Turkish hospitals with JCI and ISO certifications handle complex leiomyosarcoma surgeries and combined therapies. Clinics in Istanbul and Ankara serve 10,000+ cancer patients annually, reflecting strong experience. Coordinating ongoing chemo and radiation post-surgery is standard, which improves outcomes.
Patient Consensus: Patients note surgery alone rarely cures leiomyosarcoma; success depends on thorough chemo and radiation after. Turkish centres provide clear pathways for ongoing treatment and follow-up, essential for long-term control and quality of life.
Leiomyosarcoma in Turkey is diagnosed before surgery using high-resolution MRI and core needle biopsy. Pathologists assess tumour type and growth speed with tests like mitotic index and immunohistochemistry. This thorough approach ensures a precise diagnosis and tailored surgery planning in reputable hospitals.
Bookimed Expert Insight: Major Turkish hospitals like Lokman Hekim Istanbul Hospital combine imaging with expert pathology, delaying surgery until biopsy confirms leiomyosarcoma. This cautious approach reduces unnecessary or incomplete surgeries. Australian patients benefit by choosing JCI-accredited centres with strong oncology teams experienced in sarcoma diagnosis.
Patient Consensus: Patients in Turkey appreciate detailed MRI scans and biopsy before surgery confirms diagnosis. Many rely on second opinions and prefer centres known for sarcoma expertise. Diagnostic steps in Turkey match global standards, offering Australians confidence in thorough cancer evaluation.
Turkey offers expert leiomyosarcoma removal surgery with multidisciplinary oncology teams and high surgical precision. Leading hospitals like Lokman Hekim Istanbul Hospital carry Joint Commission International (JCI) accreditation, ensuring safe, high-quality care combined with advanced treatments and timely access.
Bookimed Expert Insight: Turkish hospitals treating sarcoma cases serve over 10,000 patients yearly, showing deep experience. Many clinics include systemic therapies like chemotherapy and immunotherapy in ongoing care. Checking JCI accreditation helps confirm international-quality standards. Clinics in Istanbul and Antalya dominate sarcoma care with modern tech and large oncology teams.
Patient Consensus: Australians choose Turkey mainly for affordable, thorough cancer care including surgery and chemo. Sarcoma treatment is well managed with expert teams. Early diagnosis and surgery plus follow-up therapies are efficiently coordinated. Access to interpreters and patient coordinators is another plus.
Choosing a clinic for leiomyosarcoma removal surgery in Turkey means finding surgeons skilled in sarcoma treatment at Joint Commission International (JCI) accredited hospitals. Facilities like Hisar Hospital Intercontinental and Medipol University Hospital offer multidisciplinary teams and advanced cancer therapies.
Bookimed Expert Insight: Clinics with 1,000+ annual patients often have teams experienced in complex sarcomas. Hisar Hospital and Medipol University feature internationally trained surgeons offering tailored multidisciplinary care, which improves outcomes for rare tumours like leiomyosarcoma.
Patient Consensus: Patients value clear communication about treatment plans in Turkey. They recommend checking surgeon credentials and appreciate hospitals that provide language support and post-op follow-up for smooth recovery.